FDA licensed a 2nd Tdap vaccine (Adacel by Sanofi Pasteur) for use in persons ages 11-64 years
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) licensed a 2nd Tdap vaccine (Adacel by…
Andras Nagy announced Canada’s first human embryonic stem cell lines
On Jun 8, 2005, Dr. Andras Nagy at Mount Sinai Hospital announced Canada’s first human embryonic stem cell…
OMRF’s Sir Alexander Fleming scholar program celebrated it’s 50th class
On Jun. 8, 2005, the Oklahoma Medical Research Foundation’s Sir Alexander Fleming scholar program celebrated it’s 50th class…
Karmanos Cancer Institute acquired clinical facilities from the Detroit Medical Center
On May 1, 2005, The Wayne State University Karmanos Cancer Institute announced it had acquired its clinical facilities…
NCI-sponsored clinical trials showed patients with early-stage, HER2-positive, invasive breast cancer experienced decrease in risk of cancer recurrence
On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…
NCI trial reported targeted agent trastuzumab and standard chemo cut risk of HER-2-positive breast cancer
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…
The National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid
On Apr. 12, 2005, the National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid. The…
Moores Cancer Center at UC San Diego opened new consolidated facility
On Apr. 8, 2005, Moores Cancer Center (MCC) at University of California, San Diego opened its new consolidated…
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
CDC announced that rubella was no longer endemic in the U.S.
On Mar. 21, 2005, the U.S. Centers for Disease Control and Prevention (CDC) announced that a major public…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 16, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
First cloned horse was born in North America
On Mar. 13, 2005, Paris Texas, the first cloned horse in North America was born at the College…
The FDA’s Drug Safety Oversight Board was formed
On Feb. 15, 2005, in response to concerns about the safety of a number of prescription medicines, the…
Autism Speaks was founded in New York City
On Feb. 11, 2005, Autism Speaks was founded in New York City by Bob and Suzanne Wright, grandparents…
The first meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Menactra by Sanofi Pasteur) was licensed
On Jan. 14, 2005, the first meningococcal polysaccharide (Serogroups A, C, Y and W-135) diphtheria toxoid conjugate vaccine…
The Institute for Translational Medicine and Therapeutics (ITMAT) was established
In Jan. 2005, the Institute for Translational Medicine and Therapeutics (ITMAT) was established at Penn’s Perelman School of…
Biotechnology | Diagnostics | Disease | FDA | Nanotechnology | Oncology | Therapeutics
FDA approved albumin-stabilized nanoparticle formulation of paclitaxel for treatment of breast cancer
In Jan. 2005, the U.S. Food and Drug Administration (FDA) approved an albumin-stabilized nanoparticle formulation of paclitaxel (Abraxane)…
Genome Alberta was established
In 2005, Genome Alberta, was established in partnership with Genome Canada Industry Canada and the Province of Alberta,…
The National Institute for Nanotechnology was founded
In 2005, the National Institute for Nanotechnology (NINT) was founded as a joint initiative between the Government of…
The California Institute for Regenerative Medicine was established
In 2005, the California Institute for Regenerative Medicine (CIRM) was formally established following the passage of Proposition 71…
The Center for Drug Discovery was established at the University of Georgia
In 2005, The Center for Drug Discovery was established at the University of Georgia to fulfill a critical…
The Penn Cardiovascular Institute (CVI) was established
In 2005, the Penn Cardiovascular Institute (CVI) was established as a collaborative multi-disciplinary group of basic and translational…
The National Cancer Institute study determined that a new molecular test can predict the risk of breast cancer recurrence
On Dec. 10, 2004, a National Cancer Institute (NCI) supported study determined that a new molecular test done…
TGen and IGC moved into their new state-of-the-art headquarters
In Dec. 2004, TGen and IGC moved into their new state-of-the-art headquarters. The six-story, $46 million building forms…
David H Murdock purchased the former Cannon Mills site at auction, future home of the North Carolina Research Campus
In Dec. 2004, David H. Murdock purchased the former Cannon Mills site at auction, future home of the…
Biotechnology | Disease | FDA | Oncology | Therapeutics
Genentech drug Tarceva (erlotinib) was approved
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Genentech’s drug Tarceva…
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Letrozole was approved by the FDA for the adjuvant treatment of early-stage breast cancer after five years of tamoxifen therapy
On Oct. 29, 2004, the U.S. Food and Drug Administration (FDA) approved Letrozole for the extended adjuvant treatment…
Linda Buck, from the Fred Hutchinson Cancer Research Center, was awarded the 2004 Nobel Prize for Medicine
On Oct. 4, 2004, the Nobel Assembly announced the award of the Nobel Prize in Physiology or Medicine…
The Hotchkiss Brain Institute was founded
In Oct. of 2004, the Hotchkiss Brain Institute was launched under the leadership of Dr. Samuel Weiss with…